Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy

BACKGROUND: Previous trials have shown improved efficacy of neoadjuvant treatment when combined with angiotensin II receptor antagonist, losartan in patients with locally advanced pancreatic ductal adenocarcinoma (PDA). However, role of losartan is unknown in metastatic PDA. In this retrospective ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi, Anup, Allen, Jessica, Mehta, Kathan, Dandawate, Prasad, Saha, Subhrajit, Bossmann, Stefan, Anant, Shrikant, Sun, Weijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177858/
https://www.ncbi.nlm.nih.gov/pubmed/34104829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177858/
https://www.ncbi.nlm.nih.gov/pubmed/34104829

Ejemplares similares